News

Institutional

July 13, 2017

3D Printing – ANVISA orders shutdown of production line of customized prostheses

The operation confirmed that prostheses were manufactured on demand of two companies, which may be subject to penalties including a fine  that may reach the maximum amount of R$ 1.5 million. This fine can also be cumulative with shutdown and cancellation of permits and licenses to operate. As a follow-up, after the investigation  of one of the companies, on  07/11/2017, ANVISA seized 60 illegal prostheses that lacked the mandatory documentation concerning its traceability. Moreover, there is evidence that some public documents could have been altered.

 

Despite Senai Joinville´s reputation with research related with 3D printing, also known as “additive manufacture”, the current episode demonstrates that regulatory compliance should be carefully dealt by research centers, even with the absence of specific regulation.

 
According to Anvisa´s Medical Devices Office interpretation, the non-existence of specific rules for customized prostheses does not exclude the applicability of the main regulations and requirements for medical devices and a prior authorization to manufacture and commercialize such materials is required. Conversely, non-compliance with such requirements may result in serious consequences for the stakeholders involved.
 
It is worth mentioning  ANVISA’s President Order 16/2017,that approved a proposal  to specifically regulate  this matter.
 
Considering the potential growth of such manufacturing method in the Brazilian market, our team is actively advising stakeholders about  the procedure nowadays imposed for 3D printing prostheses authorizations.
 
Access the original news within ANVISA’s website by clicking here and here. For further clarifications regarding the authorization procedure and the proposal to regulate this issue, do not hesitate to contact us through e-mail bio@kasznarleonardos.com
 
 
 
Back

Last related news

February 14, 2025

Chambers and Partners’ Patent Litigation Guide 2025 is now available

The Patent Litigation 2025 Guide is now available! Organized by Chambers and Partners, Kasznar Leonardos has led the chapter in Brazil. Our Chambers and Partners’ Patent Litigation Guide 2025 is now available

Ler notícia

February 13, 2025

Kasznar Leonardos is ranked in Chambers and Partners Global Guide 2025

We are pleased to announce our recognition by the Chambers and Partners Global Guide 2025. Our firm has once again been recognized Kasznar Leonardos is ranked in Chambers and Partners Global Guide 2025

Ler notícia

January 31, 2025

Kasznar Leonardos is recognized by Lexology Legal Influencers Q4 2024

We are honored to announce that Kasznar Leonardos has been recognized as a leading firm in Intellectual Property in South and Central Kasznar Leonardos is recognized by Lexology Legal Influencers Q4 2024

Ler notícia
plugins premium WordPress